Computer-aided Detection (CAD) Market (2025-2032)
The Computer-aided Detection (CAD) Market was valued at $0.89 billion in 2024. This market is expected to reach $1.56 billion by 2032, from an estimated $0.95 billion in 2025, at a CAGR of 7.4% during the forecast period 2025-2032. Computer-aided Detection (CAD) Market Size & Forecast Computer-aided
- Published
- Jan 2025
- Pages
- 260
- Format
- PDF + Excel
- Report ID
- MRHC - 1041073
- Base year
- 2024
- 2024 · BASELINE
- $890.0M
- 2032
- $1.56B
- CAGR 2025–2032
- 7.4%
2024 baseline · 2025–2032 forecast at 7.4% CAGR · hover a bar for the value
Key highlights
The Oncology Segment to Account for the Largest Market Share in 2025
The Mammography Segment to Account for the Largest Market Share in 2025
The Hospitals & Clinics Segment to Account for the Largest Market Share in 2025
Asia-Pacific to be the Fastest-growing Regional Market
Report summary
| Particulars | Details |
|---|---|
| No. of Pages | 260 |
| Format | |
| Forecast Period | 2025–2032 |
| Base Year | 2024 |
| CAGR | 7.4% |
| Market Size (Value) | $1.56 Billion |
| Segments Covered | By Application · Oncology · Breast Cancer · Lung Cancer · Liver Cancer · Colon/Rectal Cancer · Prostate Cancer · Bone Cancer · Other Cancer Types · Cardiology · Other Applications · (Note: Other applications include neurology, diabetic retinopathy, and tuberculosis.) · By Imaging Modality · Mammography · Magnetic Resonance Imaging (MRI) · Computed Tomography (CT) · Ultrasound Imaging · Other Imaging Modalities · (Note: Other imaging modalities include X-ray imaging and endoscopy.) · By End User · Hospitals & Clinics · Diagnostic Imaging Centers · Ambulatory Care and Surgery Centers |
| Countries Covered | North America (U.S., Canada), Europe (Germany, France, Italy, U.K., Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa |
| Companies Profiled | Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies Inc. (U.S.), Hologic, Inc. (U.S.), FUJIFILM Holdings Corporation (Japan), EDDA Technology, Inc. (U.S.), Canon Medical Systems Corporation (Japan), Riverain Technologies (U.S.), Median Technologies (France), Agfa-Gevaert NV (Belgium), iCAD Inc. (U.S.), CureMetrix, Inc. (U.S.), and THERAPIXEL (France) |
Report overview
Segments covered: application, modality, end user. Regions: North America, Europe, Asia-Pacific, Latin America.
Computer-aided detection is utilized in the categorization and identification of benign and malignant lesions. It assists vascular physicians in deciding the most effective treatments for patients with cardiovascular diseases using techniques such as mammography, ultrasound, and MRI. CAD technologies enhance radiologists' ability to detect and distinguish between normal and abnormal (cancerous) tissues. Furthermore, CAD is used to detect and diagnose various cancers, including breast, lung, and liver cancers. It reduces the chances of false negative/positive results in disease diagnosis.
The growth of the CAD market is driven by the rising prevalence of chronic diseases, increasing awareness regarding the importance of early cancer diagnosis, increasing investments and funding for cancer research, and rising healthcare expenditures. However, the high costs of CAD solutions restrain the growth of this market.
Additionally, the growing acceptance of CAD among radiologists, the increase in cancer screening programs, and advancements in CAD solutions, such as the integration of Artificial Intelligence (AI) and Machine Learning (ML), are expected to generate market growth opportunities. However, the lack of technical expertise required for using CAD systems is a significant challenge impacting the market's growth.
Report infographic
-Market.webp)
Market dynamics
8 factors across 2 forcesIn November 2024,
Apollo Cancer Centre (India) launched a breast cancer diagnosis program to provide rapid and accurate breast cancer diagnoses, highlighting the importance of early detection in selecting the right treatments for a higher survival rate and improving patients' quality of life.
In October 2024,
the American Liver Foundation (U.S.) conducted a free liver cancer conference for patients and their families to encourage them to take control over their health and learn more about everything from treatment options, new research advances, and clinical trials to awareness and dealing with medical side effects.
In October 2024,
the Illinois Department of Public Health (IDPH) (U.S.) launched the National Breast Cancer Awareness Program to highlight the importance of the early detection of breast cancer.
In September 2024,
the International Association for the Study of Lung Cancer (IASLC) (U.S.) launched the National Lung Cancer Early Detection Program to help identify lung cancer early through Low-dose Computed Tomography (LDCT) lung cancer screening, focusing on people with a family history of lung cancer along with those with a history of frequent smoking.
Table of contents
11 chapters · 97 sections · 260 pages · click to expandSegmental analysis
| Segment | Largest share (2025) | Fastest growth (2025–2032) |
|---|---|---|
| By Application | Oncology | — |
| By Imaging Modality | Mammography | — |
| By End User | Hospitals & Clinics | — |
By Application
- The Oncology Segment to Account for the Largest Market Share in 2025
- The oncology segment is expected to account for the largest share of the computer-aided detection market.
- The segment’s large share is attributed to the increasing prevalence of breast cancer and the increase in breast cancer detection and awareness campaigns.
- Breast cancer ranks among the most prevalent cancers affecting women globally.
- According to the World Health Organization (WHO), 2.3 million breast cancer cases were recorded globally in 2020, and this number is expected to reach 3 million by 2040.
- The rising incidence of breast cancer has led to a rapid increase in the adoption of innovative technologies, such as CAD, aimed at enhancing breast cancer detection through a combination of various modalities.
By Imaging Modality
- The Mammography Segment to Account for the Largest Market Share in 2025
- The mammography segment is expected to account for the largest share of the computer-aided detection market.
- The segment’s large share is attributed to the introduction of advanced mammography systems with cutting-edge technologies and the growing use of computer-aided detection in multispecialty hospitals.
- CAD technology improves patient outcomes by increasing the precision of mammography readings and decreasing the risk of false positives.
- Furthermore, the growth in breast cancer screening programs in developed countries also contributes to the segment’s large share.
By End User
- The hospitals & clinics segment is expected to account for the largest share of the computer-aided detection market.
- The segment’s large share is attributed to the rising prevalence of cancer, the growing number of hospitals and clinics, the availability of highly skilled professionals in hospitals and clinics, the high purchasing power of hospitals, and the increasing patient population seeking comprehensive healthcare services, including diagnosis, treatment, and surgical procedures.
Geographic analysis
Asia-Pacific
Fastest growthThe growth of this regional market is driven by rising breast cancer cases, growing awareness regarding the importance of early diagnosis and detection of cancer, cardiovascular diseases, and neurological disorders, the increase in cancer screening programs, the expansion of the healthcare sector, and increasing government investments and initiatives supporting cancer research. Asia-Pacific to be the Fastest-growing Regional Market
Competitive landscape
- Siemens Healthineers AG · Germany
- Koninklijke Philips N.V. · Netherlands
- GE HealthCare Technologies Inc. (U.S.)
- Hologic, Inc. (U.S.)
- FUJIFILM Holdings Corporation · Japan
- EDDA Technology, Inc. (U.S.)
- Canon Medical Systems Corporation · Japan
- Riverain Technologies (U.S.)
- Median Technologies · France
- Agfa-Gevaert NV · Belgium
- iCAD Inc. (U.S.)
- CureMetrix, Inc. (U.S.)
- THERAPIXEL · France
Frequently asked questions
This study provides a detailed assessment of the Computer-aided Detection (CAD) market and includes market sizes & forecasts based on application, imaging modality, and end user. The report also provides a value analysis for various segments and subsegments of the Computer-aided Detection (CAD) market at the regional and country levels.
Cite this report
Meticulous Research. (2025). Computer-aided Detection (CAD) Market - Global Opportunity Analysis and Industry Forecast (2025-2032) (Report No. MRHC - 1041073). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/computer-aided-detection-cad-market-5756